FINAFLEX
KETOTROPIN
Avoid-flaggedObjective label signals
Flagged excipients
2
1 avoid · 1 caution
FDA recalls
0
no recall history
CAERS reports
1
FDA consumer events
Certifications
0
none recorded
1 avoid-level excipient · Every flag below links to the authority's published citation.
Supplement Facts
4 active ingredients| Ingredient | Amount | % DV |
|---|---|---|
| Calories UNII · 1 | 5 Calorie(s) | — |
| Calcium UNII · SY7Q814VUP | 318 mg | 24% |
| Potassium UNII · RWP5GA015D | 29 mg | 1% |
| Total Carbohydrates CarbohydrateUNII · 0 | 2 Gram(s) | — |
Flagged excipients
2 flagged · authority citations
- ● AVOIDTitanium Dioxidecolor
Banned in EU food products effective 2022-08 (Commission Regulation (EU) 2022/63) following EFSA Panel opinion that a safe daily intake could not be established due to genotoxicity concerns. Still GRAS in the US under 21 CFR 73.575 but EU position is stricter.
- ◐ CAUTIONFD&C Red #3color
FDA revoked food/ingested-drug color additive approval for FD&C Red 3 in January 2025 (Docket FDA-2022-C-2886). Manufacturers have until January 2027 (foods) / January 2028 (ingested drugs) to reformulate.
FDA CAERS · adverse event context
1
consumer-submitted adverse event reports filed with the FDA CFSAN Adverse Event Reporting System mentioning this product or its brand.
CAERS reports are unverified consumer submissions — not adjudicated causality. Large well-known brands accumulate proportionally more reports simply due to broader use. About CAERS →
Other ingredients
Gelatin · FD&C Blue #1 · Magnesium Stearate · Silicon Dioxide